Verrill’s patent attorneys specialize in assisting biotech and life science clients at every level from university research, to startups, to mid-market and large corporations. We understand the challenges of leveraging funding for product development from dynamic research programs in a competitive environment. We’re experienced in US and foreign patent prosecution, patent litigation, post-grant proceedings, opinions related to non-infringement, invalidity, freedom to operate, inventorship disputes, licensing, portfolio analysis, and competitor analysis.

        Our patent prosecutors have extensive experience dealing with patent eligibility matters and work with a wide array of technologies including the following:

        • Antibodies
        • Aptamers
        • Aquaculture
        • Biofuels
        • Cancer therapies and vaccines
        • CAR T-cells
        • Cell culture
        • Chromatography systems
        • CRISPR technology
        • Drug delivery vehicles
        • Drug formulation
        • ELISA
        • Fluorescence in situ hybridization
        • Food science and enzymes
        • Gene therapy
        • Genetic adjuvants
        • Genomics
        • Immunotherapeutics
        • Industrial chemical and biochemical processes
        • Medical diagnostics
        • Microscopy technology and image analysis
        • Modular agricultural systems
        • Nanoparticles
        • Nucleic acids
        • Nutritional biochemistry
        • Probes
        • Proteins
        • Sequencing technology
        • Small molecule pharmaceuticals
        • Spectrometry
        • Stem cells
        • Targeting of drugs and biologics
        • Test kits
        • Transgenic animals
        • Treatment of diabetes and metabolic diseases
        • Viral vectors

        Examples of how our patent attorneys have helped their biotech clients include:

        • Quickly established a patent portfolio in the competitive CAR T-cell space to support funding efforts of a biotech startup.
        • Assisted an instrumentation company in an inventorship dispute with its research collaborator, resulting in the company establishing its own patent portfolio.
        • Obtained broad patent coverage for a biologics formulations company to support its partnering efforts.
        Experience
        Successfully obtained federal, state, and local permits for multiple expansions of Maine’s only commercial landfill facility and provides ongoing compliance and regulatory support for the landfill and associated facilities.

        Firm Highlights

        Press Releases

        Verrill Welcomes Construction Attorney Cassie Dufon

        PORTLAND, Maine – Verrill is pleased to welcome Cassie Dufon to the firm’s Construction Group as an Associate, resident in the firm’s Portland...
        Press Releases

        Verrill’s Wide-Ranging Private Wealth Law Practice Recognized in 2026 Chambers and Partners High Net Worth Guide

        BANGOR and PORTLAND, Maine and BOSTON, Mass. – Verrill attorneys Kenneth P. Brier, Anya F. Endsley, Kurt E. Klebe, Mary McQuillen, Nathaniel S....
        Blog

        Update on Status of Maine Packaging EPR

        In December 2024, Verrill published a blog post, Unwrapping Maine's Gift to the Environment: A New Packaging Stewardship Program Set to Launch in...
        Blog

        Voluntary Benefits Move into the ERISA Litigation Crosshairs

        Employee-paid accident, critical-illness, cancer, and hospital-indemnity insurance have long occupied a quiet corner of employee benefit plan...
        Alerts and Newsletters

        Maine’s New Employer Surveillance Law, 26 M.R.S. § 620-A

        Effective July 14, 2026 Maine employers that electronically monitor employees must comply with a new disclosure law effective July 14, 2026. Under...
        Press Releases

        Verrill Recognized by U.S. News as One of the Best Law Firms to Work for in 2026

        BOSTON, Mass., BANGOR and PORTLAND, Maine, GREENWICH and WESTPORT, Conn., – Verrill has been featured on U.S. News’ 2026 Best Companies to Work...
        Blog

        SECURE 2.0 Roth Catch-Up Rules and the 403(b) 15-Year Catch-Up: What Tax-Exempt Employers Need to Know

        Tax-exempt employers whose 403(b) plans offer catch-up contributions for participants age 50 and above should be well on their way to compliance with...
        Media Mentions

        Robert Keach Quoted in Law360 on SIMAD Summer Camp Bankruptcy Sale

        Verrill attorney Robert Keach was recently quoted in a Law360 article examining the Chapter 11 bankruptcy proceedings involving SIMAD Holdings and...
        Media Mentions

        Chris Tsouros Featured in Law360’s Coverage of Sports Real Estate Deals

        Verrill Partner Chris Tsouros was recently recognized in a Law360 article highlighting law firms involved in significant sports real estate projects...
        Blog

        What Maine’s New Employer Surveillance Law Means for Maine Employers

        Maine employers who monitor their workforce, whether through productivity software, GPS, call recording, or cameras, have a new compliance obligation...
        Blog

        Run Don’t Walk: The Implication of “While Supplies Last” Prize Promotions

        This month a big-chain grocery store has been offering daily mystery boxes during specific timed drops on a first-come, first-served basis, to users...
        Blog

        Maine’s Noncompete Statute is Reshaped for Health Care Workers: What You Need to Know

        Employers of individuals who are licensed under state law to perform, or provide, health care services in the State of Maine should be prepared for...